Involvement of the intrarenal renin-angiotensin system in experimental models of glomerulonephritis

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Urushihara, Maki ^a   Kinoshita, Yukiko ^a   Kondo, Shuji ^a   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; CANDESARTAN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBUCOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ACTIN FILAMENT; AUTOOXIDATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULUS; HISTOLOGY; HUMAN; IN VITRO STUDY; INFLAMMATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; GLOMERULONEPHRITIS; KIDNEY; METABOLISM; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HUMANS; KIDNEY; MODELS, BIOLOGICAL; RENIN-ANGIOTENSIN SYSTEM;

EID: 84864957232     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/601786     Document Type: Review

References (58)

1. Navar L. G., Harrison-Bernard L. M., Imig J. D., Wang C. T., Cervenka L., Mitchell K. D., Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade Journal of the American Society of Nephrology 1999 10 supplement 12 S266 S272
2. Kobori H., Nangaku M., Navar L. G., Nishiyama A., The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease Pharmacological Reviews 2007 59 3 251 287 (Pubitemid 47481436)
3. Carey R. M., Siragy H. M., The intrarenal renin-angiotensin system and diabetic nephropathy Trends in Endocrinology and Metabolism 2003 14 6 274 281 (Pubitemid 36992197)
4. Santos R. A. S., Simoes e Silva A. C., Maric C., Silva D. M. R., Machado R. P., De Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H. P., Speth R., Walther T., Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 (Pubitemid 36842532)
5. Navar L. G., Prieto-Carrasquero M. C., Kobori H., Chapter 1: Molecular Aspects of the Renal Renin-Angiotensin System 2006 1st Oxfordshine, UK Taylor Francis Medical
6. Dzau V. J., Re R., Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation 1994 89 1 493 498 (Pubitemid 24026524)
7. Baltatu O., Silva J. A. Jr., Ganten D., Bader M., The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy Hypertension 2000 35 1, part 2 409 412 (Pubitemid 30054208)
8. Dell'Italia L. J., Meng Q. C., Balcells E., Wei C. C., Palmer R., Hageman G. R., Durand J., Hankes G. H., Oparil S., Compartmentalization of angiotensin II generation in the dog heart: evidence for independent mechanisms in intravascular and interstitial spaces Journal of Clinical Investigation 1997 100 2 253 258 (Pubitemid 27349070)
9. Mazzocchi G., Malendowicz L. K., Markowska A., Albertin G., Nussdorfer G. G., Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats American Journal of Physiology 2000 278 6 E1027 E1030
10. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circulation Research 1994 74 6 1141 1148 (Pubitemid 24176909)
11. Danser A. H. J., Admiraal P. J. J., Derkx F. H. M., Schalekamp M. A. D. H., Angiotensin I-to-II conversion in the human renal vascular bed Journal of Hypertension 1998 16 12, part 2 2051 2056 (Pubitemid 29002387)
12. Navar L. G., Harrison-Bernard L. M., Nishiyama A., Kobori H., Regulation of intrarenal angiotensin II in hypertension Hypertension 2002 39 2, part 2 316 322 (Pubitemid 34165142)
13. Brasier A. R., Li J., Mechanisms for inducible control of angiotensinogen gene transcription Hypertension 1996 27 3, part 2 465 475 (Pubitemid 26086217)
14. Henrich W. L., McAllister E. A., Eskue A., Miller T., Moe O. W., Renin regulation in cultured proximal tubular cells Hypertension 1996 27 6 1337 1340 (Pubitemid 26165640)
15. Sibony M., Gasc J. M., Soubrier F., Alhenc-Gelas F., Corvol P., Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme Hypertension 1993 21 6, part 1 827 835 (Pubitemid 23171646)
16. Vo C. P., Jeanneret V. A., Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases Kidney International, Supplement 2003 64 86 S57 S63
17. Casarini D. E., Boim M. A., Stella R. C. R., Krieger-Azzolini M. H., Krieger J. E., Schor N., Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron American Journal of Physiology 1997 272 3, part 2 F405 F409
18. Kohan D. E., Angiotensin II and endothelin in chronic glomerulonephritis Kidney International 1998 54 2 646 647 (Pubitemid 28357429)
19. Urushihara M., Kobori H., Angiotensinogen expression is enhanced in the progression of glomerular disease International Journal of Clinical Medicine 2011 2 4 378 387
20. Horita Y., Tadokoro M., Taura K., Suyama N., Taguchi T., Miyazaki M., Kohno S., Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin A nephropathy Hypertension Research 2004 27 12 963 970 (Pubitemid 40425399)
21. Ruggenenti P., Perna A., Gherardi G., Gaspari F., Benini R., Remuzzi G., Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial The Lancet 1998 352 9136 1252 1256 (Pubitemid 28470337)
22. Ishizaki M., Masuda Y., Fukuda Y., Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of anti-thymocyte serum Acta Pathologica Japonica 1986 36 8 1191 1203 (Pubitemid 17173749)
23. Sakai N., Iseki K., Suzuki S., Mori T., Hagino S., Zhang Y., Yokoya S., Kawasaki Y., Suzuki J., Isome M., Wada I., Homma Y., Suzuki H., Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti-Thy1 glomerulonephritis Pathology International 2005 55 1 19 26 (Pubitemid 40289253)
24. Kawachi H., Iwanaga T., Toyabe S., Oite T., Shimizu F., Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3 Clinical and Experimental Immunology 1992 90 1 129 134
25. Nakamura T., Obata J. E., Kimura H., Ohno S., Yoshida Y., Kawachi H., Shimizu F., Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis Kidney International 1999 55 3 877 889 (Pubitemid 29100699)
26. Kondo S., Shimizu M., Urushihara M., Tsuchiya K., Yoshizumi M., Tamaki T., Nishiyama A., Kawachi H., Shimizu F., Quinn M. T., Lambeth D. J., Kagami S., Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat Journal of the American Society of Nephrology 2006 17 3 783 794
27. Gaertner S. A., Janssen U., Ostendorf T., Koch K. M., Floege J., Gwinner W., Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis Journal of the American Society of Nephrology 2002 13 12 2930 2937 (Pubitemid 35386912)
28. Budisavljevic M. N., Hodge L., Barber K., Fulmer J. R., Durazo-Arvizu R. A., Self S. E., Kuhlmann M., Raymond J. R., Greene E. L., Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis American Journal of Physiology 2003 285 6 F1138 F1148
29. Gorin Y., Ricono J. M., Wagner B., Kim N. H., Bhandari B., Choudhury G. G., Abboud H. E., Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells Biochemical Journal 2004 381, part 1 231 239 (Pubitemid 38932229)
30. Shibanuma M., Mashimo J. I., Kuroki T., Nose K., Characterization of the TGF 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence Journal of Biological Chemistry 1994 269 43 26767 26774
31. Matsuya M., Sasaki H., Aoto H., Mitaka T., Nagura K., Ohba T., Ishino M., Takahashi S., Suzuki R., Sasaki T., Cell adhesion kinase forms a complex with a new member, Hic-5, of proteins localized at focal adhesions Journal of Biological Chemistry 1998 273 2 1003 1014 (Pubitemid 28049197)
32. Tumbarello D. A., Turner C. E., Hic-5 contributes to epithelial- mesenchymal transformation through a RhoA/ROCK-dependent pathway Journal of Cellular Physiology 2007 211 3 736 747 (Pubitemid 46683042)
33. Dabiri G., Tumbarello D. A., Turner C. E., Van de Water L., Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF- 1 autocrine loop Journal of Investigative Dermatology 2008 128 10 2518 2525
34. Suga K., Kondo S., Matsuura S., Glomerular expression of hydrogen peroxide inducible clone-5 in human and rat progressive mesagnial proliferative glomerulonephritis Nephron Experimental Nephrology 2012 120 2 e59 e68
35. Nishimoto S., Nishida E., MAPK signalling: ERK5 versus ERK1/2 EMBO Reports 2006 7 8 782 786 (Pubitemid 44275395)
36. Bokemeyer D., Panek D., Kramer H. J., Lindemann M., Kitahara M., Boor P., Kerjaschki D., Trzaskos J. M., Floege J., Ostendorf T., In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis Journal of the American Society of Nephrology 2002 13 6 1473 1480 (Pubitemid 34579236)
37. Masaki T., Stambe C., Hill P. A., Dowling J., Atkins R. C., Nikolic-Paterson D. J., Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies Journal of the American Society of Nephrology 2004 15 7 1835 1843 (Pubitemid 38822062)
38. Suzaki Y., Yoshizumi M., Kagami S., Nishiyama A., Ozawa Y., Kyaw M., Izawa Y., Kanematsu Y., Tsuchiya K., Tamaki T., BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions Kidney International 2004 65 5 1749 1760 (Pubitemid 38591023)
39. Urushihara M., Takamatsu M., Shimizu M., ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis American Journal of Physiology Renal Physiology 2009 298 1 F167 F176
40. Okada H., Inoue T., Kikuta T., Watanabe Y., Kanno Y., Ban S., Sugaya T., Horiuchi M., Suzuki H., A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade American Journal of Pathology 2006 169 5 1577 1589 (Pubitemid 351181990)
41. Ohashi N., Urushihara M., Satou R., Kobori H., Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen speciesERK/JNK pathways Hypertension Research 2010 33 11 1174 1181
42. Lakshmanan A. P., Thandavarayan R. A., Watanabe K., Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice Molecular and cellular endocrinology 2012 348 1 104 111
43. Ha H., Hi Bahl Lee, Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose Kidney International, Supplement 2000 58 77 S19 S25
44. Tomlinson D. R., Mitogen-activated protein kinases as glucose transducers for diabetic complications Diabetologia 1999 42 11 1271 1281 (Pubitemid 29500963)
45. Tsiani E., Lekas P., Fantus I. G., High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor American Journal of Physiology 2002 282 1 E161 E169
46. Hudson B. G., Tryggvason K., Sundaramoorthy M., Neilson E. G., Alport's syndrome, Goodpasture's syndrome, and type IV collagen The New England Journal of Medicine 2003 348 25 2543 2556 (Pubitemid 36706542)
47. Shimizu M., Kondo S., Urushihara M., Takamatsu M., Kanemoto K., Nagata M., Kagami S., Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis Nephrology Dialysis Transplantation 2006 21 9 2380 2390 (Pubitemid 44644508)
48. Wada T., Yokoyama H., Furuichi K., Kobayashi K. I., Harada K., Naruto M., Shao-Bo S. U., Akiyama M., Mukaida N., Matsushima K., Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1) The FASEB Journal 1996 10 12 1418 1425
49. Kinoshita Y., Kondo S., Urushihara M., Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis Translational Research 2011 158 4 235 248
50. Wada T., Furuichi K., Sakai N., Iwata Y., Yoshimoto K., Shimizu M., Kobayashi K. I., Mukaida N., Matsushima K., Yokoyama H., A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats Journal of the American Society of Nephrology 2000 11 8 1534 1541 (Pubitemid 30483471)
51. Matsushima K., Larsen C. G., DuBois G. C., Oppenheim J. J., Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line Journal of Experimental Medicine 1989 169 4 1485 1490 (Pubitemid 19104979)
52. Ozawa Y., Kobori H., Suzaki Y., Navar L. G., Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions The American Journal of Physiology 2007 292 1 F330 F339
53. Segerer S., Cui Y., Hudkins K. L., Goodpaster T., Eitner F., Mack M., Schlndorff D., Alpers C. E., Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis Journal of the American Society of Nephrology 2000 11 12 2231 2242
54. Urushihara M., Ohashi N., Miyata K., Satou R., Acres O. W., Kobori H., Addition of angiotensin II Type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis Hypertension 2011 57 3 586 593
55. Wada T., Matsushima K., Kobayashi K. I., Monocyte chemoattractant protein-1: does it play a role in diabetic nephropathy? Nephrology Dialysis Transplantation 2003 18 3 457 459 (Pubitemid 36305644)
56. Kato S., Luyckx V. A., Ots M., Lee K. W., Ziai F., Troy J. L., Brenner B. M., Mackenzie H. S., Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats Kidney International 1999 56 3 1037 1048 (Pubitemid 29411731)
57. Zoja C., Corna D., Rottoli D., Cattaneo D., Zanchi C., Tomasoni S., Abbate M., Remuzzi G., Effect of combining ACE inhibitor and statin in severe experimental nephropathy Kidney International 2002 61 5 1635 1645 (Pubitemid 34437917)
58. Chen Y. M., Hu-Tsai M. I., Lin S. L., Tsai T. J., Hsieh B. S., Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats Nephrology Dialysis Transplantation 2003 18 12 2505 2514